Scalper1 News
Shares of Tekmira Pharmaceuticals and other drugmakers involved in Ebola treatments rose Wednesday after officials disclosed the first case of Ebola initially diagnosed on U.S. soil late Tuesday. Tekmira Pharmaceuticals (TKMR) shares jumped 20.8% to 25.50 by midafternoon trading in the stock market today. In August, Tekmira said that the U.S. Food and Drug Administration had moved its TKM-Ebola drug to a partial clinical hold status from a full Scalper1 News
Scalper1 News